Most dosing plans begin with a low weekly dose, commonly 12 mg
Of note, over the last years, an array of unimolecular GLP1-based poly-agonists, with different mechanisms of action, have been developed and experimentally validated for the treatment of metabolic syndrome, holding superior efficacy relative to conventional GLP1-RA 33,34,35
This would mandate coverage of prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved weight loss medications, without imposing stricter rules than those approved by the FDA
GLP-1 (Glucagon-Like Peptide-1) is a hormone your body naturally produces in the gut after you eat
Get in touch with our office to learn from our specialists in a one-on-one consultation
In terms of safety, generally more events and events leading to discontinuation were reported in the patient group aged of 65 years or more